Several studies observed high levels of tumor-infiltrating lymphocytes (TILs) and of PD-L1 [37] in HER2-positive breast cancers, demonstrating a correlation between high levels of TILs with better prognosis, higher rates of pathological complete response (pCR), disease-free survival (DFS), and OS [38]. Here, ERBB2 is linked to breast cancer.